Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
aescolab logo — Gesundheitspartner für HR & BGM zur Stärkung von Leistungsfä...

aescolab

Gesundheitspartner für HR & BGM zur Stärkung von Leistungsfähigkeit und Arbeitgebermarke | Blutanalyse, personalisierte

Founded 2024 Germany Berlin, Germany 14 employees Seed

General Information

Company Name aescolab
Founded Year 2024
Location Germany Berlin, Germany
Employees 14
Funding Stage Seed
Business Model B2C, D2C, B2B
Revenue Model Product Sales, Service Fee, Subscription
Hiring 1 role posted in the month to 25 Sep 2026
Social

BounceWatch is an independent company data service, not affiliated with aescolab. To contact aescolab, visit aescolab.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Sep 14, 2026

Hiring for 1 position in the last 30 days.

Get alerts when aescolab shows new signals

About aescolab

aescolab is a healthcare-focused startup, established in 2024, aiming to transform preventive healthcare via high-quality blood-biomarker analysis paired with individualized lifestyle recommendations. Their mission is encapsulated in their slogan: "High-quality blood-biomarker analysis and individualized lifestyle recommendations."

Based in Germany, aescolab targets individuals who experience fatigue and lack of energy, providing them with personalized insights to take proactive health measures. The company has strategically entered the German market to address the growing need for accessible and high-quality health diagnostics.

Supported by the influential Danish impact venture studio, KRING, aescolab successfully attracted a Seed investment from KRING on 01 June 2025. This backing not only legitimizes the business model but positions aescolab as a promising investment opportunity in the burgeoning preventive healthcare industry.

Taxonomy: blood-biomarker analysis, individualized lifestyle recommendations, preventive healthcare, fatigue management, energy optimization, healthtech innovation, personalized healthcare, wellness solutions, impact venture-backed, health diagnostics, bioinformatics, health data analytics

Services & Products

Comprehensive Blood Analysis
Health and Energy Improvement Plans
Actionable Health Recommendations
Continuous Support and Follow-Up
Coaching Portal Access
Personalized Reports
Video Consultations

Target Customers

Individuals Seeking Health Improvement Companies Focused on Employee Health Healthcare Professionals Partner Practices in Germany, Austria, Switzerland

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Undisclosed 1
KRING
KRING
01 Jun 2025

aescolab Alternatives & Competitors

View All Alternatives
aescolab vs
Medpass Brasil
Medpass Brasil Brazil

Tecnologia e inteligência médica: a garantia de saúde para pessoas e empresas.

Seed
7 employees
Health Care, Information Technology
aescolab vs
Advanx Health
Advanx Health Malaysia

Enabling Personalized Health| Malaysia's Top 101 Healthcare and IT Startup 2021 | Malaysia's Top 58...

6 employees
Health Care, Health and Wellness
aescolab vs
Diagnostikare
Diagnostikare Mexico

Innovando en salud, cultivando bienestar.

Seed
36 employees
Care Economy, Digital Health
View all alternatives

FAQ About aescolab

Gesundheitspartner für HR & BGM zur Stärkung von Leistungsfähigkeit und Arbeitgebermarke | Blutanalyse, personalisierte
aescolab was founded in 2024.
aescolab is headquartered in Berlin, Germany.
aescolab has a B2C, D2C and B2B business model. Its revenue comes from Product Sales, Service Fee and Subscription.
aescolab has approximately 14 employees.
aescolab has completed 1 funding round. The latest funding stage is Seed.
aescolab offers: Comprehensive Blood Analysis, Health and Energy Improvement Plans, Actionable Health Recommendations, Continuous Support and Follow-Up, Coaching Portal Access, Personalized Reports, Video Consultations.
Top alternatives and competitors to aescolab include Medpass Brasil, Advanx Health, Diagnostikare, Bioqare, RxLongevity. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
aescolab and Medpass Brasil are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for aescolab, https://bouncewatch.com/company/aescolab, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes